Cargando...
Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer
The advent of rationally targeted therapies such as small-molecule tyrosine kinase inhibitors (TKIs) has considerably transformed the therapeutic management of a subset of patients with non-small-cell lung cancer (NSCLC) harboring defined molecular abnormalities. When such genetic molecular alterati...
Gardado en:
| Publicado en: | Front Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220657/ https://ncbi.nlm.nih.gov/pubmed/25414829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00281 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|